“The future role of tau PET in clinical practice and trials”

In the rapidly evolving field of Alzheimer’s Disease biomarkers, scientists strive to improve trial designs and diagnostic processes in clinical practice. With this survey study we will explore how dementia clinicians, researchers and clinical trialists envision the future role of tau PET in clinical practice and in trials. If you are interested to participate, you can leave your e-mail address here and the online survey will be sent to you. Filling out the survey will take 15 to 20 minutes of your time and participation can be anonymous.